ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Bioptix, Inc.
7.67
0.0000
成交量:
- -
成交額:
- -
市值:
4,144.87萬
市盈率:
-6.24
高:
7.67
開:
7.67
低:
7.67
收:
7.67
52周最高:
11.17
52周最低:
2.32
股本:
540.40萬
流通股本:
450.40萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-1.2300
淨資產收益率:
--
總資產收益率:
--
市淨率:
3.76
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Bioptix, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.bioptix.com/
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Bioptix, Inc.致力於推進解決未滿足的人類診斷需求的產品。 Bioptix,Inc.於2000年7月24日作為科羅拉多州公司組織生產用於診斷應用的純化蛋白質。 到目前為止,該公司已利用公司的科學技術推進公司APPY1產品候選人的開發,並開發了動物健康相關資產,包括知識產權。 2012年,公司對這些動物健康相關資產進行了授權,如下所述。 公司的研究和開發活動目前主要集中在人類急性闌尾炎基於血液的測試。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BIOP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","market":"US","secType":"STK","nameCN":"Bioptix, Inc.","latestPrice":7.67,"timestamp":1508356800000,"preClose":7.67,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":4503971,"shares":5404000,"eps":-1.23,"marketStatus":"退市","change":0,"latestTime":"03-24 16:17:15 EDT","open":7.67,"high":7.67,"low":7.67,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.23,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.67,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOP\",,,,,undefined,":{"symbol":"BIOP","floatShares":4503971,"roa":"--","roe":"--","lyrEps":0,"shares":5404000,"dividePrice":0,"high":7.67,"amplitude":0,"preClose":7.67,"low":7.67,"week52Low":2.32,"pbRate":"3.76","week52High":11.17,"institutionHeld":0,"latestPrice":7.67,"eps":-1.23,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.23,"open":7.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOP\",params:#limit:5,,,undefined,":[{"date":"2017-10-19","symbol":"BIOP","newSymbol":"RIOT","type":"symbolChange","dateTimestamp":1508385600000},{"market":"US","date":"2017-10-12","symbol":"BIOP","amount":1,"name":"Bioptix, Inc.","currency":"USD","type":"dividend","dateTimestamp":1507780800000},{"market":"US","date":"2017-08-11","symbol":"BIOP","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1502424000000,"reportTimeType":"","actualEps":-0.21},{"market":"US","date":"2017-05-15","symbol":"BIOP","fiscalQuarterEnding":"2017/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1494820800000,"reportTimeType":"","actualEps":-0.22},{"market":"US","date":"2016-11-14","symbol":"BIOP","fiscalQuarterEnding":"2016/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1479099600000,"reportTimeType":"","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":[{"executeDate":"2017-10-12","recordDate":null,"paymentDate":null,"value":1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.bioptix.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Bioptix, Inc.致力於推進解決未滿足的人類診斷需求的產品。 Bioptix,Inc.於2000年7月24日作為科羅拉多州公司組織生產用於診斷應用的純化蛋白質。 到目前為止,該公司已利用公司的科學技術推進公司APPY1產品候選人的開發,並開發了動物健康相關資產,包括知識產權。 2012年,公司對這些動物健康相關資產進行了授權,如下所述。 公司的研究和開發活動目前主要集中在人類急性闌尾炎基於血液的測試。","exchange":"NASDAQ","name":"Bioptix, Inc.","nameEN":"Bioptix, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BIOP\",market:\"US\",,,undefined,":null}}